Reply to Dookie et al., “Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis”

Claudio U. Köser; Jan Heyckendorf; Sönke Andres; Ioana D. Olaru; Thomas Schön; Erik Sturegård; Patrick Beckert; Viola Schleusener; Thomas A. Kohl; Doris Hillemann; Danesh Moradigaravand; Julian Parkhill; Sharon J. Peacock; Stefan Niemann; Christoph Lange; Matthias Merker

doi:10.1128/AAC.00616-18

Reply to Dookie et al., “Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis”

Claudio U. Köser, Jan Heyckendorf, Sönke Andres, Ioana D. Olaru, Thomas Schön, Erik Sturegård, Patrick Beckert, Viola Schleusener, Thomas A. Kohl, Doris Hillemann, Danesh Moradigaravand, Julian Parkhill, Sharon J. Peacock, Stefan Niemann, Christoph Lange^*, Matthias Merker

^*Korrespondierende/r Autor/-in für diese Arbeit

Medizinische Klinik III

Originalsprache	Englisch
Aufsatznummer	e00616-18
Zeitschrift	Antimicrobial Agents and Chemotherapy
Jahrgang	62
Ausgabenummer	8
ISSN	0066-4804
DOIs	https://doi.org/10.1128/AAC.00616-18
Publikationsstatus	Veröffentlicht - 08.2018

Fördermittel

This study was funded by the German Ministry of Education and Research (BMBF) for the German Center of Infection Research (DZIF) and the Health Innovation Challenge Fund (grants HICF-T5-342 and WT098600), a parallel-funding partnership between the UK Department of Health and the Wellcome Trust.

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen

Strategische Forschungsbereiche und Zentren

Forschungsschwerpunkt: Infektion und Entzündung - Zentrum für Infektions- und Entzündungsforschung Lübeck (ZIEL)

Dokumente

10.1128/AAC.00616-18

Weitere Links

Link to publication in Scopus

Zitieren

Köser, C. U., Heyckendorf, J., Andres, S., Olaru, I. D., Schön, T., Sturegård, E., Beckert, P., Schleusener, V., Kohl, T. A., Hillemann, D., Moradigaravand, D., Parkhill, J., Peacock, S. J., Niemann, S., Lange, C., & Merker, M. (2018). Reply to Dookie et al., “Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis”. Antimicrobial Agents and Chemotherapy, 62(8), Artikel e00616-18. https://doi.org/10.1128/AAC.00616-18

@article{6070176a35c441a8a0525e2a7e500492,

title = "Reply to Dookie et al., “Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis”",

author = "K{\"o}ser, \{Claudio U.\} and Jan Heyckendorf and S{\"o}nke Andres and Olaru, \{Ioana D.\} and Thomas Sch{\"o}n and Erik Stureg{\aa}rd and Patrick Beckert and Viola Schleusener and Kohl, \{Thomas A.\} and Doris Hillemann and Danesh Moradigaravand and Julian Parkhill and Peacock, \{Sharon J.\} and Stefan Niemann and Christoph Lange and Matthias Merker",

note = "Funding Information: This study was funded by the German Ministry of Education and Research (BMBF) for the German Center of Infection Research (DZIF) and the Health Innovation Challenge Fund (grants HICF-T5-342 and WT098600), a parallel-funding partnership between the UK Department of Health and the Wellcome Trust. Copyright: Copyright 2018 Elsevier B.V., All rights reserved.",

year = "2018",

month = aug,

doi = "10.1128/AAC.00616-18",

language = "English",

volume = "62",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "8",

}

Köser, CU, Heyckendorf, J, Andres, S, Olaru, ID, Schön, T, Sturegård, E, Beckert, P, Schleusener, V, Kohl, TA, Hillemann, D, Moradigaravand, D, Parkhill, J, Peacock, SJ, Niemann, S, Lange, C & Merker, M 2018, 'Reply to Dookie et al., “Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis”', Antimicrobial Agents and Chemotherapy, Jg. 62, Nr. 8, e00616-18. https://doi.org/10.1128/AAC.00616-18

TY - JOUR

T1 - Reply to Dookie et al., “Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis”

AU - Köser, Claudio U.

AU - Heyckendorf, Jan

AU - Andres, Sönke

AU - Olaru, Ioana D.

AU - Schön, Thomas

AU - Sturegård, Erik

AU - Beckert, Patrick

AU - Schleusener, Viola

AU - Kohl, Thomas A.

AU - Hillemann, Doris

AU - Moradigaravand, Danesh

AU - Parkhill, Julian

AU - Peacock, Sharon J.

AU - Niemann, Stefan

AU - Lange, Christoph

AU - Merker, Matthias

N1 - Funding Information: This study was funded by the German Ministry of Education and Research (BMBF) for the German Center of Infection Research (DZIF) and the Health Innovation Challenge Fund (grants HICF-T5-342 and WT098600), a parallel-funding partnership between the UK Department of Health and the Wellcome Trust. Copyright: Copyright 2018 Elsevier B.V., All rights reserved.

PY - 2018/8

Y1 - 2018/8

UR - https://www.scopus.com/pages/publications/85050778828

U2 - 10.1128/AAC.00616-18

DO - 10.1128/AAC.00616-18

M3 - Letters

C2 - 30054377

AN - SCOPUS:85050778828

SN - 0066-4804

VL - 62

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 8

M1 - e00616-18

ER -